EICHORCondition: Hidradenitis Suppurativa · Sponsor: Incyte Corporation
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Investigative Site US257 | Birmingham, Alabama, United States | — |
| Investigative Site US218 | Birmingham, Alabama, United States | — |
| Investigative Site US239 | Montgomery, Alabama, United States | — |
| Investigative Site US215 | Phoenix, Arizona, United States | — |
| Investigative Site US261 | Phoenix, Arizona, United States | — |
| Investigative Site US240 | Tucson, Arizona, United States | — |
| Investigative Site US262 | Encino, California, United States | — |
| Investigative Site US222 | Fountain Valley, California, United States | — |
| Investigative Site US211 | Los Angeles, California, United States | — |
| Investigative Site US237 | Los Angeles, California, United States | — |
| Investigative Site US234 | Northridge, California, United States | — |
| Investigative Site US250 | Santa Ana, California, United States | — |
+ 95 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06958211